Continuous Manufacturing to increase productivity

Many pharma manufacturers are adopting continuous production: Active ingredients are produced in compact, closed, highly automated units with fewer manual interventions, and sequential classic batch production steps are integrated into continuous processes. Continuous production makes classic batch processes look outdated: asset utilization up 30-40%, and products taking 1-2 months are finished in 2 days.

Process Analytical Technology (PAT) forms the basis for Continuous Manufacturing, determining clinical efficacy of an ingredient via direct online in-process quality data. Our SIMATIC SIPAT, widely considered one of the most advanced PAT software, helps pharma manufacturers boost system capacity by 1/3 and reduce production costs by 10-20% after just a short time.

A move to continuous manufacturing can be a big step for pharmaceutical companies. The in-silico innovations such as digital twin's and associated data platforms, and all the additional applications around it, have accelerated this branch of innovation making it more imperative than ever before. Watch the video giving a view on some state-of-the-art solutions and their benefits.